Skip to main content

CBMT11074 / NMDP 10-CBA / Jane Liesveld

Research Question:
What is the incidence of neutrophil recovery of ≥500/mm3 after cord blood transplantation in a multi-institution setting using CBUs that are not Food and Drug Administration (FDA) licensed?

Basic Study Information

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

Location: University of Rochester Medical Center
Study Reference #: CBMT11074-

Lead Researcher (Principal Investigator)

Lead Researcher:  Jane Liesveld, MD

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email:

Additional Study Details

Return to Search